Guillot, Pete http://orcid.org/0000-0001-8247-7272
Shea, John http://orcid.org/0000-0002-2566-7018
Shoemaker, Scarlett http://orcid.org/0000-0003-3708-8846
Rocco, Michael http://orcid.org/0000-0001-6440-9671
DeLuca, Michael http://orcid.org/0000-0001-5556-8312
Rai, Rena http://orcid.org/0000-0001-7128-5881
Hermes-DeSantis, Evelyn R. http://orcid.org/0000-0001-5658-3899
Article History
Accepted: 6 March 2023
First Online: 5 April 2023
Declarations
:
: No funding was provided for the preparation of this article.
: PG is employed by Centerfirst, JS is employed by EMD Serono, SS is employed by Eli Lilly and Company, MR is employed by Pfizer Inc., MD is employed by Eversana, Medical Affairs, RR is employed by Janssen Scientific Affairs, LLC, and ERHD is employed by phactMI. JS, SS, MR, MD, and RR are members of phactMI. The authors have no other potential conflicts of interest to declare.
: Not applicable.
: All surveys were voluntarily completed by participants. All data were anonymized.
: No participant information is published.
: The data are not publicly available.
: No coding was used in the article.
: All authors substantially contributed to all aspects of authorship, including conception and design; interpretation; and drafting and revising the final work. PG was responsible for data acquisition, and analysis of Centerfirst data. All authors read and approved the final manuscript draft for submission and agreed to be accountable for all aspects of the work.